StockData
MCTANasdaqServices-Misc Health & Allied Services, NEC

Charming Medical Ltd

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 30, 2026
$29.36+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Charming Medical Ltd revenue by segment

By business segment

By product or service

RevenueFY2026FY2025FY2024% of revenueYoY
Beauty, wellness and postpartum services$4.51M$5.97M$5.81M93.8%-24.4%
Sales of Products [Member]$163.38K$207.77K$88.99K3.4%-21.4%
Franchise [Member]$135.83K$46.71K–2.8%+190.8%
Pre-Opening Service [Member]$46.71K––1.0%–
Consultancy services––$112.57K––

By region

From the segment and revenue-disaggregation notes of Charming Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.